Jena, Germany

Friedrich Bergter

This inventor holds 1 USPTO granted patent. Top assignee: Veb Jenapharm. Active years: 1989.


% Patents Active = 100.0

Average Co-Inventor Count = 18.0

ph-index = 1


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Friedrich Bergter: Innovator in Antibiotic Production

Introduction

Friedrich Bergter is a notable inventor based in Jena, Germany. He has made significant contributions to the field of antibiotic production, particularly through his innovative processes. His work has led to advancements in the fermentative production of important antibiotics.

Latest Patents

Bergter holds a patent for a process titled "Process for the production of nourseothricine and its adsorbate." This patent describes a method for the fermentative production of the antibiotic nourseothricin. The process utilizes various carbohydrate sources, suitable nitrogen sources, and mineral salts to cultivate high concentrations of this antibiotic in culture solutions. The recovery of the active substance can be achieved through chromatographic techniques or by adding a physiologically compatible adsorbent, which can be incorporated into mixed feed agents.

Career Highlights

Bergter's career is marked by his work at Veb Jenapharm, where he has been instrumental in developing antibiotic production methods. His innovative approaches have contributed to the advancement of pharmaceutical manufacturing processes.

Collaborations

Throughout his career, Bergter has collaborated with notable colleagues, including Klaus-Dieter Menzel and Ernst-Joachim Bormann. These collaborations have further enhanced the research and development of antibiotic production techniques.

Conclusion

Friedrich Bergter's contributions to antibiotic production through his patented processes have had a lasting impact on the pharmaceutical industry. His innovative methods continue to influence the field of antibiotic research and development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…